Robert Kitchen, PhD

The Kitchen laboratory ( specialises in computational biology, functional genomics, and non-invasive diagnostics.  With a focus on the computational and statistical analyses of the RNA, protein, and metabolites produced by healthy and unhealthy tissues/cell-types we define markers of various diseases that can be detected in blood, urine, and cerebrospinal fluid.  We apply state-of-the-art statistical/machine-learning approaches and leverage the massive power and flexibility of cloud-computing to define novel biomarkers of cardiovascular disease, type 2 diabetes, neurodegenerative diseases, and various cancers.  Recently the lab have become active contributors to Mass-General Brigham’s COVID-19 Innovation effort, helping to evaluate low-cost serologic (antibody/immunity) and diagnostic (viral RNA/protein detection) technologies before they are deployed to the greater Boston area and beyond.

Dr. Kitchen received his PhD in Physics from the University of Edinburgh in 2011 and completed his post-doctoral training at Yale University under the mentorship of Mark Gerstein (Systems Biology) and Angus Nairn (Molecular Psychiatry).  Prior to joining MGH and Harvard Medical School, he spent 3 years at Exosome Diagnostics where, as a Senior Informatics Scientist, he made substantial contributions to several biomarker development and companion-diagnostics programs prior to the company’s successful acquisition by Bio-Techne in 2018.  He is an active member of several large and productive consortia including FOUNDIN-PD, PsychENCODE, and the Extracellular RNA Communication Consortium (ERCC); and he currently serves as co-chair of the ERCC’s Data Analysis working group. 

Contact Info:

Massachusetts General Hospital
Cardiovascular Research Center
149 13th Street, 4.017
Charlestown, MA 02129


[javascript protected email address]
Kitchen Lab